Co-delivery of rituximab targeted curcumin and imatinib nanostructured lipid carriers in non-Hodgkin lymphoma cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Co-delivery of rituximab targeted curcumin and imatinib nanostructured lipid carriers in non-Hodgkin lymphoma cells
Authors
Keywords
-
Journal
JOURNAL OF LIPOSOME RESEARCH
Volume -, Issue -, Pages 1-15
Publisher
Informa UK Limited
Online
2020-03-06
DOI
10.1080/08982104.2020.1720718
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PEGylated trimethylchitosan emulsomes conjugated to octreotide for targeted delivery of sorafenib to hepatocellular carcinoma cells of HepG2
- (2019) Jaleh Varshosaz et al. JOURNAL OF LIPOSOME RESEARCH
- Apoptosis-promoting effect of rituximab-conjugated magnetic nanoprobes on malignant lymphoma cells with CD20 overexpression
- (2019) Lina Song et al. International Journal of Nanomedicine
- Influence of Dissolution Media and Presence of Alcohol on the In Vitro Performance of Pharmaceutical Products Containing an Insoluble Drug
- (2018) Valeria Friuli et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- A developed antibody–drug conjugate rituximab-vcMMAE shows a potent cytotoxic activity against CD20-positive cell line
- (2018) Meghdad Abdollahpour-Alitappeh et al. Artificial Cells Nanomedicine and Biotechnology
- Romidepsin alone or in combination with anti-CD20 chimeric antigen receptor expanded natural killer cells targeting Burkitt lymphoma in vitro and in immunodeficient mice
- (2017) Yaya Chu et al. OncoImmunology
- THPdb: Database of FDA-approved peptide and protein therapeutics
- (2017) Salman Sadullah Usmani et al. PLoS One
- Exploitation of redox discrepancy in leukemia cells by a reactive oxygen species nanoscavenger for inducing cytotoxicity in imatinib resistant cells
- (2016) Sarbari Acharya et al. JOURNAL OF COLLOID AND INTERFACE SCIENCE
- Curcumin potentiates the anti-leukemia effects of imatinib by downregulation of the AKT/mTOR pathway and BCR/ABL gene expression in Ph+ acute lymphoblastic leukemia
- (2015) Yong Guo et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Rituximab-conjugated and doxorubicin-loaded microbubbles combined with ultrasound irradiation inhibits proliferation and induces apoptosis in Raji cell lines
- (2015) SHOUBING ZHOU et al. ONCOLOGY REPORTS
- Enhanced oral bioavailability and anticancer activity of novel curcumin loaded mixed micelles in human lung cancer cells
- (2015) Sharvil Patil et al. PHYTOMEDICINE
- Curcumin derivative C817 inhibits proliferation of imatinib-resistant chronic myeloid leukemia cells with wild-type or mutant Bcr-Abl in vitro
- (2014) Li-xian Wu et al. ACTA PHARMACOLOGICA SINICA
- Curcumin Induces Caspase Mediated Apoptosis in JURKAT Cells by Disrupting the Redox Balance
- (2014) Priya Kalyan Gopal et al. Asian Pacific Journal of Cancer Prevention
- Nanostructured lipid carriers and their current application in targeted drug delivery
- (2014) Piyush Jaiswal et al. Artificial Cells Nanomedicine and Biotechnology
- Synthesis and Characterization of Folate-Targeted Dextran/Retinoic Acid Micelles for Doxorubicin Delivery in Acute Leukemia
- (2014) J. Varshosaz et al. Biomed Research International
- Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes
- (2013) J. Ruan et al. BLOOD
- Imatinib tackles lymphoma via the PDGFR + pericyte
- (2013) J. P. Chute et al. BLOOD
- Regulation of CD20 in Rituximab-Resistant Cell Lines and B-cell Non-Hodgkin Lymphoma
- (2012) P.-C. Tsai et al. CLINICAL CANCER RESEARCH
- Curcumin Suppresses T Cell Activation by Blocking Ca 2+ Mobilization and Nuclear Factor of Activated T Cells (NFAT) Activation
- (2012) Christian Kliem et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of Differentially Expressed Proteins in Curcumin-Treated Prostate Cancer Cell Lines
- (2012) Marie-Hélène Teiten et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- Curcumin enhances the response of non-Hodgkin’s lymphoma cells to ionizing radiation through further induction of cell cycle arrest at the G2/M phase and inhibition of mTOR phosphorylation
- (2012) QIAO QIAO et al. ONCOLOGY REPORTS
- Effects of oral curcumin on the pharmacokinetics of intravenous and oral etoposide in rats: possible role of intestinal CYP3A and P-gp inhibition by curcumin
- (2011) Chong-Ki Lee et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Overexpression of P-glycoprotein induces acquired resistance to imatinib in chronic myelogenous leukemia cells
- (2011) Xing-Xiang Peng et al. Chinese Journal of Cancer
- Effect of imatinib therapy with and without turmeric powder on nitric oxide levels in chronic myeloid leukemia
- (2011) Veena S Ghalaut et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies
- (2010) Jenny Epstein et al. BRITISH JOURNAL OF NUTRITION
- Potential of the Dietary Antioxidants Resveratrol and Curcumin in Prevention and Treatment of Hematologic Malignancies
- (2010) Mareike Kelkel et al. MOLECULES
- Curcumin―The Paradigm of a Multi-Target Natural Compound with Applications in Cancer Prevention and Treatment
- (2010) Marie-Hélène Teiten et al. Toxins
- Gene Expression Profiling Related to Anti-inflammatory Properties of Curcumin in K562 Leukemia Cells
- (2009) Marie-Helene Teiten et al. Annals of the New York Academy of Sciences
- Effect of Curcumin on Nuclear Factor κB Signaling Pathways in Human Chronic Myelogenous K562 Leukemia Cells
- (2009) Simone Reuter et al. Annals of the New York Academy of Sciences
- Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
- (2009) G. Bar-Sela et al. CURRENT MEDICINAL CHEMISTRY
- Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells
- (2008) Simone Reuter et al. BIOCHEMICAL PHARMACOLOGY
- Curcumin and cancer: An “old-age” disease with an “age-old” solution
- (2008) Preetha Anand et al. CANCER LETTERS
- Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins
- (2008) Ajaikumar B. Kunnumakkara et al. CANCER LETTERS
- Curcumin: From ancient medicine to current clinical trials
- (2008) H. Hatcher et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer
- (2008) N. Dhillon et al. CLINICAL CANCER RESEARCH
- Curcumin as “Curecumin”: From kitchen to clinic
- (2007) Ajay Goel et al. BIOCHEMICAL PHARMACOLOGY
- Rituximab associated to imatinib for coexisting therapy-related chronic myeloid leukaemia and relapsed non-Hodgkin lymphoma
- (2007) Massimo Breccia et al. LEUKEMIA RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started